Skip to main content

Table 4 Associations between HCWs’ attitudes and their intentions to vaccinate in cross-sectional studies

From: Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review

Authors

Setting

Study population/response rate

Determinant (attitude)

Intention to vaccinate

Measure of association

Adjustments

Gonik et al. (2000) [19]

USA

313/43% Obstetrician-gynecologists

Assess routinely the patients for vaccine- preventable diseases

Reported habit to administer vaccines

Spearman rho correlation 0.30–0.70; p < 0.05

None

Zimmerman et al. (2002) [22]

USA

281/72,4% general practitioners, family practice, pediatricians

Agreement with the national recommendations on varicella vaccination. Yes vs no

Would recommend the vaccination

In children 12–18 months: 98%

1A,1C, 1D,3E, 1F

vs 3%, p < 0.05

Children 4–6 years: 93%

vs 19%, p < 0.05

Children 11–12 years:

86% vs 68%, p < 0.05

Taylor et al. (2002) [21]

USA

112/? pediatricians

A) Number of injections willing to give in one visit. Range 1 to 6 (>5)

Increase of record linked vaccine coverage

A) Per each injection more: Increase at 8 months of 3.6% (95% CI 0.4-6.8) p > 0.05, at 19 months 1.5% (95% CI −2.8 - 5.5) p > 0.05

2B, 1C, 3E

B) Recommendation of inactivated polio vaccine (IPV) vs oral vaccine

B) Using IPV: Increase at 8 months of 8.9% (95% CI 3.3-15.4) p < 0.05, at 19 months 15.4% (95% CI 7.7 - 23.1) p < 0.05

Schupfner et al. (2002) [20]

Germany

97/73% pediatricians

Prefer to give combined vaccines than separate

Reported vaccine coverage rate

100% in those with high reported coverage (>80%) vs 81% in low coverage (<80%) p > 0.05

2C,4D,4E

Milledge et al. (2003) [24]

Australia

160/67% general practitioners

Concerns about varicella vaccine: A) Immunity may not be life-long

Would recommend universal varicella vaccination

A) OR 0.60 (95%CI 0.33-1.21) p > 0.05

1B, 1C, 7E, 2F

B) Increase in herpes zoster

B) OR 1.08 (0.33-3.6) p > 0.05

C) More serious varicella disease in adults

C) OR 0.92 (0.37-2.27) p > 0.05

D) Possible, unknown side effects

D) OR: 0.31 (0.15–0.63) p > 0.05

Davis et al. (2003) [23]

USA

694/60% family physicians

A) Considers giving 5 injections at 1 visit vs less

Reported habit of recommending the vaccine

A) OR 17.29 (95% CI 6.35, 47.05) p < 0.05

4E, 1F

B) Considers giving 4 injections at 1 visit vs less

B) OR 8.69(95% CI 4.21, 17.94) p < 0.05

Jungbauer-Gans et al. (2003) [25]

Germany

136/71% family physicians and pediatricians

Importance of the officially recommended vaccinations (Index: 1 = not at all, 5 = very)

Reported habit of recommending full vaccination

Index of 4.8 in those recommending full vaccination vs 3.9 in those who did not. p < 0.05

None

  

94/71% family physicians and pediatricians

Importance of the officially recommended vaccinations (same Index)

Record linked vaccine coverage

One point increase in the Index was associated with an increase of 25.8% in the coverage. p < 0.05

None

Wilson et al. (2004) [26]

Canada

312/59,4% naturopathic students

Trust in Public Health information

Willingness to advise full vaccination

OR 3.72 (95% CI 1.42–10.7) p < 0.05

1D, 5E

Clark et al. (2006) [29]

USA

183/54% obstetricians

Perceive to have a role in promote Tdap vaccination to other adults (not mothers) in contact with infants

Report to recommend Tdap vaccine to pregnant women

77% perceive having a role in those recommending vaccine to pregnant women vs 50% in those who do not. p < 0.05

None

Davis et al. (2007) [30]

USA

336/49% family physicians, general internists

Agree that pertoussis is serious enough to warrant using Tdap in adults. Yes vs no or neutral

Would recommend the vaccination if recommended

93% vs 68%. p < 0.05

None

Gust et al. (2008) [31]

USA

733/65% family physicians, pediatricians

Have some concerns about immunization

Recommend full immunization

OR 0.32 (95% CI 0.56-0.19) p < 0.05

1C, 1D, 1E